Showing 121 - 140 results of 27,434 for search '(( 5 ht decrease ) OR ( 50 ((((ns decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.75s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    Human 5-HT<sub>4</sub>-based RASSLs. by Wei Chun Chang (43479)

    Published 2007
    “…Rs1.2 is Rs1 with an extra D<sup>66</sup>A mutation that decreased constitutive G<sub>s</sub> signaling. Rs1.3 is the Rs1-i3-5-HT<sub>1A</sub> chimera with G<sub>i</sub> signaling. …”
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  13. 133

    ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes. by Fangrui Ding (659863)

    Published 2014
    “…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”
  14. 134

    WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

    Published 2013
    “…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [<sup>3</sup>H]-Thymidine incorporation assay. …”
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140